BEIJING: GSK plc (LSE/NYSE: GSK) said Tuesday that China’s National Medical Products Administration has approved Shingrix, its recombinant zoster vaccine (RZV), for use in adults aged 18 and older who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by disease or therapy. The approval marks the first shingles vaccine authorized in…
NEW YORK: Bristol Myers Squibb (NYSE: BMY, BMS) and Orbital Therapeutics have entered into a definitive agreement in which BMS will acquire Orbital, a privately held biotech firm at the forefront of developing next-generation RNA-based therapies. Orbital’s platform focuses on in vivo immune system reprogramming, offering highly targeted, adaptable treatments designed to address the intricate…
LONDON: International Biotechnology Trust PLC announced Wednesday it has entered into an agreement with Schroders Capital to establish a partnership aimed at investing in unquoted biotechnology companies. The new partnership is designed to provide the Company’s shareholders with long-term access to a diversified portfolio of earlier-stage, private biotechnology firms. The Company intends to make an…
PARIS: Sanofi Ventures has announced an additional $625 million multi-year capital commitment from Sanofi, increasing its total assets under management to over $1.4 billion. This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative biotech and digital health companies that align with Sanofi’s long-term growth ambitions. “This…
Revenue for the six months ended June 30 rose to £2.2 million from £1.6 million a year earlier LONDON: Creo Medical Group plc (AIM: CREO), a UK-based medical device company specializing in minimally invasive surgical endoscopy, reported a 40% rise in first-half revenue, driven by increased clinical adoption of its core product portfolio. Revenue for…
· Includes new $1.2 billion investment announced today in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs · New facilities will bridge R&D and manufacturing across both the U.S. and U.K., strengthening the two countries’ leadership in life sciences LONDON: GSK plc (LSE/NYSE: GSK) today announced plans to invest $30 billion…
SALT LAKE CITY: Cosentus Holdings, a leading provider of integrated business solutions for healthcare practices, has signed an agreement to acquire Alta Management Solutions, a respected firm specializing in medical practice consulting and revenue cycle management (RCM). The acquisition, finalized on May 27, 2025, strengthens Cosentus’ national presence and enhances its service offerings. Based in…